IRIS
PEDEMONTE, NICOLETTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.357
AS - Asia 156
NA - Nord America 22
SA - Sud America 17
AF - Africa 1
Totale 1.553
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 1.352
SG - Singapore 62
CN - Cina 43
VN - Vietnam 33
US - Stati Uniti d'America 17
BR - Brasile 12
HK - Hong Kong 7
MX - Messico 5
AR - Argentina 4
ID - Indonesia 3
BD - Bangladesh 2
DE - Germania 2
RU - Federazione Russa 2
IN - India 1
JP - Giappone 1
KZ - Kazakistan 1
NP - Nepal 1
PY - Paraguay 1
SA - Arabia Saudita 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
UA - Ucraina 1
Totale 1.553
Salva come PNG Salva come JPEG
Città #
Genoa 967
Vado Ligure 180
Rapallo 123
Genova 73
Beijing 15
Singapore 13
Ho Chi Minh City 11
Ashburn 8
Hong Kong 7
Biên Hòa 4
Bordighera 4
Hanoi 4
Milan 4
Los Angeles 3
Mexico City 3
Ninh Bình 2
Almaty 1
Asunción 1
Bandung 1
Banyuwangi 1
Buenos Aires 1
Bắc Giang 1
Campinas 1
Chelsea 1
Chicago 1
Cidade Ocidental 1
Coatepec Harinas 1
Cícero Dantas 1
El Ouardia 1
Erechim 1
Frankfurt am Main 1
Garibaldi 1
Gobernador Virasoro 1
Haiphong 1
Hải Dương 1
Iguape 1
Jackson 1
Jakarta 1
Jeddah 1
Jingmen 1
José Bonifácio 1
Merlo 1
New York 1
Olivos 1
Passos 1
Patna 1
Paulista 1
Phúc Yên 1
Ribeirão Preto 1
Santa Clara 1
Sarlahi 1
St Petersburg 1
Sóc Trăng 1
Thái Bình 1
Thái Nguyên 1
Tianjin 1
Tokyo 1
Torres 1
Torreón 1
Turiisk 1
Tây Ninh 1
Vĩnh Tường 1
Xiamen 1
Totale 1.468
Salva come PNG Salva come JPEG
Nome #
Targeting of Ubiquitin E3 Ligase RNF5 as a Novel Therapeutic Strategy in Neuroectodermal Tumors 110
The L467F-F508del Complex Allele Hampers Pharmacological Rescue of Mutant CFTR by Elexacaftor/Tezacaftor/Ivacaftor in Cystic Fibrosis Patients: The Value of the Ex Vivo Nasal Epithelial Model to Address Non-Responders to CFTR-Modulating Drugs 106
Journey on VX-809-Based Hybrid Derivatives towards Drug-like F508del-CFTR Correctors: From Molecular Modeling to Chemical Synthesis and Biological Assays 99
Partial rescue of f508del-cftr stability and trafficking defects by double corrector treatment 93
LEAD OPTIMIZATION OF MKT-077 ANALOGUES AS HSP70 ALLOSTERIC INHIBITORS COMBINED WITH F508DEL CFTR CORRECTORS: A MULTI DRUG APPROACH TO CONTRAST CYSTIC FIBROSIS 91
Neutrophil Extracellular Traps in Systemic Lupus Erythematosus Stimulate IgG2 Production From B Lymphocytes 90
Genotype-phenotype correlations and disease mechanisms in PEX13-related Zellweger spectrum disorders 88
Cyclic diacyl thioureas enhance activity of corrector Lumacaftor on F508del‐CFTR 88
Comprehensive analysis of combinatorial pharmacological treatments to correct nonsense mutations in the cftr gene 87
Probing Allosteric Hsp70 Inhibitors by Molecular Modelling Studies to Expedite the Development of Novel Combined F508del CFTR Modulators 81
Rescue by elexacaftor-tezacaftor-ivacaftor of the G1244E cystic fibrosis mutation's stability and gating defects are dependent on cell background 80
Patient's dermal fibroblasts as disease markers for visceral myopathy 71
Simultaneous Quantification of Ivacaftor, Tezacaftor, and Elexacaftor in Cystic Fibrosis Patients’ Plasma by a Novel LC–MS/MS Method 69
De novo variants in DENND5B cause a neurodevelopmental disorder 66
Clinical Consequences and Functional Impact of the Rare S737F CFTR Variant and Its Responsiveness to CFTR Modulators 59
Therapeutic monitoring of Ivacaftor, Tezacaftor and Elexacaftor in patients with cystic fibrosis|Monitoraggio terapeutico di Ivacaftor, Tezacaftor e Elexacaftor in pazienti con fibrosi cistica 52
QUANTIFICATION OF IVACAFTOR, TEZACAFTOR, AND ELEXACAFTOR IN PLASMA OF CYSTIC FIBROSIS PATIENTS BY AN HPLC–MS/MS METHOD 49
Virtual Drug Repositioning as a Tool to Identify Natural Small Molecules That Synergize with Lumacaftor in F508del-CFTR Binding and Rescuing 47
Quantification of Ivacaftor, Tezacaftor and Elexacaftor in plasma of cystic fibrosis patients treated with Kaftrio by a validated liquid chromatography-tandem mass spectrometric (LC-MS/MS) method” 45
Pharmacological rescue of the G85E CFTR variant by preclinical and approved modulators 45
A Novel LC-MS/MS Method for the Measurement of Elexacaftor, Tezacaftor and Ivacaftor in Plasma, Dried Plasma Spot (DPS) and Whole Blood in Volumetric Absorptive Microsampling (VAMS) Devices 36
Structure-guided combination of novel CFTR correctors to improve the function of F508del-CFTR in airway epithelial cells 20
null 18
In silico, in vitro and ex vivo characterization of cystic fibrosis transmembrane conductance regulator pathogenic variants localized in the fourth intracellular loop and their rescue by modulators 13
Totale 1.603
Salva come PNG Salva come JPEG
Categoria #
all - tutte 7.071
article - articoli 6.424
book - libri 0
conference - conferenze 647
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.142
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202289 0 4 2 1 0 2 1 10 8 18 33 10
2022/2023157 8 12 5 10 22 10 4 14 27 1 35 9
2023/2024150 5 10 6 18 12 18 20 8 9 7 15 22
2024/2025696 15 28 27 38 32 74 43 166 58 75 72 68
2025/2026511 139 22 93 96 139 22 0 0 0 0 0 0
Totale 1.603